Cite
HARVARD Citation
Spiegelstein, O. et al. (2019). A Thorough QT/QTc Study With Laquinimod, a Novel Immunomodulator in Development for Multiple Sclerosis and Huntington Disease. Clinical pharmacology in drug development. 8 (1), pp. 49-59. [Online].